Madrigal Pharmaceuticals, Inc. (MDGL)
NASDAQ: MDGL · Real-Time Price · USD
497.35
-7.60 (-1.51%)
At close: Jan 21, 2026, 4:00 PM EST
496.97
-0.38 (-0.08%)
After-hours: Jan 21, 2026, 4:15 PM EST

Madrigal Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Jan '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
11,2956,7304,5685,1791,4491,719
Upgrade
Market Cap Growth
67.84%47.33%-11.79%257.45%-15.74%22.31%
Upgrade
Enterprise Value
10,5365,8514,4525,0751,1511,384
Upgrade
Last Close Price
504.95308.57231.38290.2584.74111.17
Upgrade
PS Ratio
15.1237.36----
Upgrade
PB Ratio
18.328.9211.2726.247.397.17
Upgrade
P/TBV Ratio
18.288.9811.2726.247.397.17
Upgrade
EV/Sales Ratio
14.2332.48----
Upgrade
Debt / Equity Ratio
0.550.160.290.250.000.00
Upgrade
Asset Turnover
0.610.21----
Upgrade
Quick Ratio
3.135.795.353.103.526.10
Upgrade
Current Ratio
3.446.105.383.123.546.13
Upgrade
Return on Equity (ROE)
-41.22%-80.35%-123.98%-150.12%-110.92%-61.61%
Upgrade
Return on Assets (ROA)
-15.78%-36.98%-47.41%-57.71%-54.09%-35.44%
Upgrade
Return on Capital Employed (ROCE)
-31.70%-57.00%-72.90%-119.00%-123.40%-86.00%
Upgrade
Earnings Yield
-2.56%-6.92%-8.18%-5.70%-16.69%-11.76%
Upgrade
FCF Yield
-1.43%-6.79%-7.13%-4.35%-12.71%-9.18%
Upgrade
Buyback Yield / Dilution
-6.98%-13.83%-9.05%-3.64%-7.05%-0.34%
Upgrade
Updated Nov 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q